Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer Has Tafamidis Data In Hand, But Market Development Still A Challenge

Aug 27 2018

• By Joseph Haas

Anatomy of Human Heart

Related Content

Alnylam's Onpattro Carries Narrower hATTR Indication Without Cardiac Data

Aug 14 2018

Aimovig And Tegsedi In Raft Of Products To Get EMA Thumbs up

Jun 01 2018

Start-Up Eidos Surfs Crest Of TTR Amyloidosis Wave

Aug 27 2018

Pfizer May Enjoy Blockbuster Cardiomyopathy Success With Tafamidis

Apr 02 2018

Related Companies

Pfizer Inc.

Alnylam Pharmaceuticals Inc.

Ionis Pharmaceuticals, Inc.

Eidos Therapeutics, Inc.

Additional Topics

Clinical Trials Research & Development Commercial Business Strategies Rare Diseases Cardiovascular BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.